Abstract
Background Plasmablastic lymphoma (PBL) is an unusual non-Hodgkin lymphoma (NHL) most commonly found in the head and neck region. The majority of cases are seen in adult HIV-positive patients, although PBL has been reported in HIV-negative patients. The diagnosis of PBL serves as an AIDS-defining illness. Methods We report a case of PBL localized to the oral cavity in a previously undiagnosed AIDS patient. The lesion manifested as solitary, ulcerated, and markedly tender. PBL was confirmed by immunohistochemical profile and subsequent tests confirmed AIDS diagnosis. The patient was prescribed highly active antiretroviral therapy (HAART) and concomitant local low dose radiation therapy prior to initiation of chemotherapy. Results Complete local clinical response was observed after 4 weeks of treatment with HAART and radiation therapy. The response sustained in this patient in the subsequent 11 months following diagnosis. Conclusions The diagnosis of PBL has a unique immunophenotypic profile and should raise suspicion for AIDS in these patients. HAART added to treatment has shown improved survival.
References
Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413–20.
Biggar RJ. AIDS-related cancers in the era of highly active antiretroviral therapy. Oncology. 2001;15:439–48.
Eltom MA, Jemal A, Mbulaiteye SM, et al. Trends in Kaposi’s sarcoma and non-Hodgkin’s lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94:1204–10.
Nasta SD, Carrum GM, Shahab I, et al. Regression of plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma. 2002;43:423–6.
Berretta M, Cinelli R, Martellotta F, et al. Therapeutic approaches to AIDS-related malignancies. Oncogene. 2003;42:6646–59.
Cioc AM, Allen C, Kalmar JR, et al. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol. 2004;28:41–6.
Diamond C, Taylor TH, Aboumrad T, et al. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer. 2006;106:128–35.
Appleby P, Beral V, Carpenter L, et al. The impact of highly active antiretroviral therapy and the incidence of cancer in people infected with the human immunodeficiency virus. International collaboration on HIV and cancer unit. J Natl Cancer Inst. 2000;92:1823–30.
Gates A, Kaplan L. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Huntingt). 2002;16:441–51.
Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogeneous spectrum in both HIV-positive and -negative patients. Ann Oncol. 2004;15:1673–9.
Chetty R, Hlatswayo N, Sabaratnam R, et al. Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology. 2003;42:605–9.
Duarte ECB, Silveira-Junior JB, Gomez RS, et al. Plasmablastic lymphoma of oral mucosa type: a case report. Oral Oncol Extra. 2005;41:121–4.
Porter SR, Diz Dios P, Kumar N, et al. Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Radiol Endod. 1999;87:730–4.
Antinori AA, Cingolani AB, Alba LA, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001;15:1483–91.
Little RF, Pittaluga S, Grant N, et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood. 2003;101:4653–9.
Lin Y, Rodrigues GD, Turner JF, et al. Plasmablastic lymphoma of the lung. Report of a unique case and review of the literature. Arch Pathol Lab Med. 2001;125:282–5.
Lin F, Zhang K, Quiery AT Jr, et al. Plasmablastic lymphoma of cervical lymph nodes in a human immunodeficiency virus-negative patient. A case report and review of the literature. Arch Pathol Lab Med. 2004;128:581–4.
Scheper MA, Nikitakis NG, Fernandes R, et al. Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:198–206.
Nguyen DD, Loo BW, Tillman G, et al. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol. 2003;82:512–5.
Lester R, Phillips P, Shenkier TN, et al. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma. 2004;45:1881–5.
Brown RS, Cambell C, Lishman SC, et al. Plasmablastic lymphoma: a new subcategory of human immunodeficiency virus-related non-Hodgkin’s lymphoma. Clin Oncol (R Coll Radiol). 1998;10:327–9.
Desai RS, Vanaki SS, Puranik RS, et al. Plasmablastic lymphoma presenting as gingival growth in a previously undiagnosed HIV-positive patient: a case report. J Oral Maxillofac Surg 2007;65:1358–61.
Diamond C, Taylor TH, Aboumrad T, et al. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer. 2005;106:128–35.
Gates A, Kaplan L. AIDS malignancies in the era of highly active antiretroviral therapy. Oncol (Huntingt). 2002;16:657–65.
Noy A. Update in HIV-associated lymphoma. Curr Opin Oncol. 2004;16:450–4.
Levine AM, Seneviratne L, Tulpule A. Incidence and management of AIDS-related lymphoma. Oncology (Williston Park). 2001;15:629–39.
Vaccher E, Spina M, di Gennaro G, et al. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin’s lymphoma. Cancer. 2001;91:155–63.
Navarro WH, Kaplan LD. AIDS-related lymphoproliferative disease. Blood. 2006;107:13–20.
Gaidano G, Cerri M, Capelo D, et al. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol. 2002;119:622–8.
Dong HY, Scadden DT, de Leval L, Tang Z, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol. 2005;29:1633–41.
Redmond M, Quinn J, Murphy P, et al. Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn’s disease after immunosuppressive therapy. J Clin Pathol. 2007;60:80–1.
Pruneri G, Graziadei G, Ermellino L, et al. Plasmablastic lymphoma of the stomach. A case report. Haematologica. 2008;83(1):87–9.
Tavora F, Gonzalez-Cuyar LF, Sun CJ, et al. Extra-oral plasmablastic lymphoma: report of a case and review of literature. Hum Pathol. 2006;37(9):1233–6.
Schichman SA, McClure R, Schaefer RF, Mehta P. HIV and plasmablastic lymphoma manifesting in anus, testicles and bones: a further expansion of the disease spectrum. Am J Hematol. 2004;77:291–5.
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vieira, F.O., El Gandour, O., Buadi, F.K. et al. Plasmablastic Lymphoma in a Previously Undiagnosed Aids Patient: A Case Report. Head and Neck Pathol 2, 92–96 (2008). https://doi.org/10.1007/s12105-008-0058-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-008-0058-1